# US 2021/0239707 A1 · Reagents and methods for elemental mass spectrometry of biological samples

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0239707 A1
- Document ID: US20210239707A1
- Status: Published application
- Kind: A1
- Application number: 17/050,716
- Filed: 2019-04-26
- Published: 2021-08-05
- Earliest claimed: 2018-04-27
- Assignees: Fluidigm Canada Inc.
- Applicants: Fluidigm Canada Inc.
- Inventors: Alexander V. Loboda; Olga Ornatsky; Vladimir Baranov; Nikita Zabinyakov; Anastasia Mavropoulos; Daniel Majonis; Bedilu Allo; Taunia Closson
- Web page: https://patentgrep.com/patent/US20210239707A1

## CPC

- G01N 33/6848: {Methods of protein analysis involving mass spectrometry}
- H01J 49/0009: {Calibration of the apparatus}
- C07K 1/13: Labelling of peptides
- G01N 1/04: in the solid state, e.g. by cutting
- G01N 1/28: Preparing specimens for investigation {including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q}(mounting specimens on microscopic slides G02B21/34; means for supporting the objects or the materials to be analysed in electron microscopes H01J37/20 {; laboratory gas handling apparatus B01L5/00})
- G01N 1/4022: {by thermal techniques; Phase changes}
- G01N 2001/045: {Laser ablation; Microwave vaporisation}
- G01N 2458/15: Non-radioactive isotope labels, e.g. for detection by mass spectrometry
- G01N 2560/00: Chemical aspects of mass spectrometric analysis of biological material
- H01J 49/0409: {Sample holders or containers (containers for retaining a material to be analyzed, B01L3/50, for DNA, C12Q1/6834, for biological materials, G01N33/543)}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- H01J: ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS (spark-gaps H01T; electric arc lamps H05B31/00; particle accelerators H05H)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

Embodiments of the present invention relate to reagents and their use for elemental imaging mass spectrometry of biological samples. The embodiments comprising methods for quantifying one or more analytes within a sample, comprising the steps of: (a) providing the sample, wherein the one or more analytes are immobilized to a sample carrier, wherein the sample has been labelled with one or more mass tags comprising one or more labelling atoms, (b) performing mass cytometry on the sample to determine the level of the one or more labelling atoms, wherein the level of the one or more labelling atoms corresponds to the copy number of the one or more analytes.

## Claims

### Claim 1

A method for quantifying one or more analytes within a sample, comprising the steps of:
a. providing the sample, wherein the one or more analytes are immobilised to a mass cytometry sample carrier, wherein the sample has been labelled with one or more mass-tagged SBPs comprising one or more labelling atoms, and
b. performing mass cytometry on the sample to determine a level of the one or more labelling atoms, wherein the level of the one or more labelling atoms corresponds to the copy number of the one or more analytes to quantify the analytes.

### Claim 2 (depends on 1)

The method of claim 1, wherein the quantitation of the analytes resulting from performing mass cytometry is:
a. relative, or
b. absolute, comprising comparison of the level of the one or more labelling atoms to a calibration curve.

### Claim 3

A mass cytometry sample carrier comprising a substrate and a surface modification, wherein one or more capture elements are immobilised to the surface modification.

### Claim 4 (depends on 3)

The mass cytometry sample carrier according to claim 3, wherein the surface modification is at least one of (i) a surface assembled monolayer, or (ii) a 3D polymer.

### Claim 5 (depends on 4)

The mass cytometry sample carrier according to claim 4, wherein the surface assembled monolayer comprises a silane, an alkylthiol, or an alkyl bromide.

### Claim 6 (depends on 4, 5)

The mass cytometry sample carrier according to claim 4 or claim 5, wherein:
the surface modification is the 3D polymer,
the 3D polymer is a 3D polymer brush, and
the 3D polymer brush projects perpendicularly away from the surface of the sample carrier.

### Claim 7 (depends on 6)

The mass cytometry sample carrier according to claim 6, wherein the 3D polymer brush is:
a. an acrylate-based polymer brush;
b. a zwitterionic polymer brush; or
c. a carbohydrate hydrogel.

### Claim 8 (depends on 3, 4, 5)

The mass cytometry sample carrier according to any one of claims 3-5, wherein the one or more capture elements comprise one or more of the following:
a. a protein comprising a monoclonal antibody, a polyclonal antibody, a bispecific antibody, a multispecific antibody, an antibody fusion protein, scFv, antibody mimetic, avidin, streptavidin, neutravidin, biotin, or a combination thereof, wherein optionally the antibody mimetic comprises a nanobody, affibody, affilin, affimer, affitin, alphabody, anticalin, avimer, DARPin, Fynomer, kunitz domain peptide, monobody, a receptor, a receptor-Fc fusion, a ligand, a ligand-Fc fusion, a lectin, an agglutinin, wheat germ agglutinin, or any combination thereof;
b. a peptide comprising a linear peptide, a cyclical peptide, a bicyclic peptide, or phalloidin; or
c. a nucleic acid comprising a polynucleotide, oligonucleotide, DNA, RNA, cDNA, a polynucleotide analog, xeno nucleic acid (XNA), bridged nucleic acid (BNA), glycol nucleic acid (GNA), peptide nucleic acids (PNAs), yPNAs, morpholino polynucleotides, locked nucleic acids (LNAs), threose nucleic acid (TNA), 2′-0-Methyl polynucleotides, 2′-0-alkyl ribosyl substituted polynucleotides, phosphorothioate polynucleotides, or boronophosphate polynucleotides.

### Claim 9 (depends on 3, 4, 5)

The mass cytometry sample carrier of any one of claims 3-5, comprising a plurality of discrete regions to which one or more capture elements are immobilised.

### Claim 10 (depends on 9)

The mass cytometry sample carrier of claim 9 in which:
a. at least two discrete regions of the plurality of discrete regions have different capture elements or combinations thereof immobilised to them; and/or
b. at least two discrete regions of the same sample carrier may have the same capture elements immobilised to them.

### Claim 11 (depends on 9)

The mass cytometry sample carrier of claim 9, wherein a plurality of different capture elements are immobolised to each discrete region of the plurality of discrete regions.

### Claim 12 (depends on 3, 4, 5)

The mass cytometry sample carrier of any one of claims 3-5, wherein the sample carrier substrate is selected from the group consisting of inorganic materials, organic materials, metals, noble metals, metal oxides, mica, silica, ceramics, polymers, glass, plastic, nanoparticles, and polymer beads.

### Claim 13 (depends on 3, 4, 5)

The mass cytometry sample carrier of any one of claims 3-5, wherein the sample carrier substrate is planar, a polymer bead, or a nanoparticle).

### Claim 14 (depends on 3, 4, 5)

The mass cytometry sample carrier of any one of claims 3-5, wherein the sample carrier substrate is planar and further comprises a polydopamine layer.

### Claim 15 (depends on 1)

The method of claim 1, wherein the mass cytometer sample carrier comprises a substrate and a surface modification, wherein one or more capture elements are immobilised to the surface modification.

### Claim 16 (depends on 1)

The method of claim 1, wherein the mass cytometer sample carrier is planar and comprises a polydopamine layer.

### Claim 17 (depends on 15, 16)

The method of claim 15 or 16, wherein the one or more analytes are immobilised to the sample carrier via one or more capture elements.

### Claim 18 (depends on 1, 2, 15)

The method of any one of claims 1, 2, 15, or 16, wherein the method further comprises sampling and ionizing sample material to form sample ions, and analysing said ions in a mass detector.

### Claim 19 (depends on 18)

The method of claim 18, in which the sampling and ionisation comprises:
a. laser ablation followed by separate ionisation of the sample material in an ICP to form sample ions; or
b. laser desorption ionisation (LDI) to form sample ions.

### Claim 20 (depends on 18)

The method of claim 18, in which the sampling and ionisation comprises particulate mass cytometry sample carriers from a solution and introducing a particulate material individually into an ionisation system to form sample ions.

### Claim 21 (depends on 2)

The method of claim 2, wherein:
the quantitation is absolute, and
the calibration curve comprises at least two points.

### Claim 22 (depends on 2)

The method of claim 2, wherein:
the quantitation is absolute, and
the calibration curve is determined prior to analysis of the sample.

### Claim 23 (depends on 2)

The method of claim 2, wherein:
the quantitation is absolute, and
the calibration curve is determined based on a set of doped polystyrene beads or set of nanoparticles, wherein each member of the set contains a known quantity of one or more labelling atoms.

### Claim 24 (depends on 1)

The method of claim 1, wherein the mass tag of the mass tagged SBP is:
a. a metal chelating moiety which has been loaded with at least one metal labelling atom;
b. a nanoparticle comprising at least one labelling atom; or
c. a polymer comprising at least one labelling atom in its backbone.

### Claim 25 (depends on 24)

The method of claim 24 wherein the metal chelating moiety is:
a. a polymer having a degree of polymerization of between approximately 1 and 10,000; and/or
b. a polymer comprising between approximately 1 and 10,000 metal-chelating groups, wherein each metal chelating group comprise 1,4,7,10-tetraazacycloidodecane-1,4,7,10-tetraacetic acid (DOTA), diethylene triamine pentaacetic acid (DTPA), or combinations thereof, and wherein each metal chelating group is attached to a polymer subunit derived from either a substituted polyacrylate, polyacrylamide, polymethacrylate, or polymethacrylamide.

### Claim 26 (depends on 24, 25)

The method of claim 24 or 25 wherein the labelling atom(s) have an atomic mass in the range 80-250.

### Claim 27 (depends on 24, 25)

The method of claim 24 or 25, wherein all labelling atoms in a mass tag are of the same atomic mass.

### Claim 28 (depends on 24, 25)

The method of any of claim 24 or 25, at least one mass tag comprises labelling atoms of differing atomic mass.

### Claim 29 (depends on 1, 2, 15, 16)

The method of any one of claims 1, 2, 15, 16, or 21-25, wherein the one or more mass-tagged SBPs comprise one or more of the following:
a. a protein comprising a monoclonal antibody, a polyclonal antibody, a bispecific antibody, a multispecific antibody, an antibody fusion protein, scFv, antibody mimetic, avidin, streptavidin, neutravidin, biotin, a nanobody, affibody, affilin, affimer, affitin, alphabody, anticalin, avimer, DARPin, Fynomer, kunitz domain peptide, monobody, a receptor, a receptor-Fc fusion, a ligand, a ligand-Fc fusion, a lectin, an agglutinin, wheat germ agglutinin, or a combination thereof;
b. a peptide comprising a linear peptide, a cyclical peptide, a bicyclic peptide, or phalloidin; or
c. a nucleic acid comprising a polynucleotide, oligonucleotide, DNA, RNA, cDNA, a polynucleotide analog, xeno nucleic acid (XNA), bridged nucleic acid (BNA), glycol nucleic acid (GNA), peptide nucleic acids (PNAs), yPNAs, morpholino polynucleotides, locked nucleic acids (LNAs), threose nucleic acid (TNA), 2′-0-Methyl polynucleotides, 2′-0-alkyl ribosyl substituted polynucleotides, phosphorothioate polynucleotides, or boronophosphate polynucleotides.

### Claim 30

A sample carrier for mass cytometry, the sample carrier comprising:
an element standard, the element standard comprising particles, film, and/or a polymer that comprise one or more elements or isotopes.

### Claim 31

A sample carrier for mass cytometry, wherein analytes in a sample are specifically bound by capture elements on the mass cytometry sample carrier.

### Claim 32 (depends on 31)

The sample carrier of claim 31, wherein the sample carrier further comprises an element standard, the element standard comprising particles, film, and/or a polymer that comprise one or more elements or isotopes.
